GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Treasury Stock

Progen Co (XKRX:296160) Treasury Stock : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Progen Co Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Progen Co's treasury stock for the quarter that ended in Dec. 2024 was ₩0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Progen Co Treasury Stock Historical Data

The historical data trend for Progen Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Progen Co Treasury Stock Chart

Progen Co Annual Data
Trend Dec23
Treasury Stock
-

Progen Co Quarterly Data
Dec23 Dec24
Treasury Stock - -

Progen Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Progen Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Progen Co Ltd (XKRX:296160) » Definitions » Treasury Stock
Comparable Companies
XKRX:032790 XKRX:038070 XKRX:263050 XKRX:308080 XKRX:222110 XKRX:456570 XKRX:142760 XKRX:348080 XKRX:168330 XKRX:389030 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Website
http://www.progen.co.kr
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.

Progen Co Headlines

No Headlines